Skip to main content

Table 1 Sample information

From: Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes

ID

Age

Sex

RNA Yield (ng/ml)

PAXgene yield

(% Tempus)

RIN

PAXgene

Tempus

PAXgene

Tempus

Normal controls in PAXgene and Tempus tubes for RNA extraction

 Control-1

73

M

5510

6572

84

7.0

7.5

 Control-2

33

M

1082

1339

81

8.0

7.9

 Control-3

37

M

3262

3598

91

7.4

7.7

 Control-4

51

M

3716

2279

163

7.1

9.1

 Control-5

26

M

3826

3324

115

7.8

8.8

 Control-6

63

M

1071

2636

41

7.7

7.6

 Control-7

32

M

1007

1858

54

7.8

9.5

 Control-8

30

M

3676

3930

94

7.0

8.5

 Control-9

40

F

4669

5772

81

7.7

7.5

TrialNet type 1 diabetes patient samples in Tempus tubes

ID

Age

Sex

Duration (y)

Serum Auto-antibodiesa

RIN

 TN-T1D1

23

M

2.25

GAD65, ICA512, mIAA, ICA

7.4

 TN-T1D2

23

F

2.25

GAD65, ICA512, mIAA

8.4

 TN-T1D3

26

F

2.28

GAD65, mIAA

7.8

 TN-T1D4

13

F

2.26

ICA512, mIAA, ICA

8.5

 TN-T1D5

40

M

2.22

GAD65, ICA512, mIAA

8.6

 TN-T1D6

18

F

2.26

GAD65, mIAA

8.2

 TN-T1D7

18

M

2.24

GAD65, ICA512, mIAA

7.6

 TN-T1D8

14

F

2.24

GAD65, mIAA

7.6

 TN-T1D9

16

F

2.19

ICA512, mIAA, ICA

7.3

 TN-T1D10

16

M

2.28

GAD65, ICA512, mIAA

8.3

University of Florida type 1 diabetes patient samples in PAXgene tubes

ID

Age

Sex

Duration (y)

Serum Auto-antibodiesa

RIN

 UF-T1D1

17

F

2.67

GADA, IA-2

9.7

 UF-T1D2

16

M

2.42

Not detected

7.1

 UF-T1D3

16

M

2.00

GADA, IA-2, ZnT8

9.1

 UF-T1D4

19

F

2.33

GADA

7.9

 UF-T1D5

17

F

2.25

GADA, IA-2, ZnT8

8.8

 UF-T1D6

27

M

1.92

GADA, IA-2, ZnT8

8.0

Normal controls for RNA extraction and lysate preparation

ID

Age

Sex

RNA Yield (ng/ml)

PAXgene yield

(% Tempus)

RIN

PAXgene

Tempus

PAXgene

Tempus

 Sample 1

19

M

1508

4690

32

6.3

9.0

 Sample 2

19

M

947

3088

31

8.4

8.8

 Sample 3

20

F

1441

4897

29

8.6

8.0

 Sample 4

19

F

2982

3383

88

8.7

8.6

 Sample 5

19

M

2604

3249

80

9.2

8.6

 Sample 6

24

M

2016

905

223

8.2

8.7

 Sample 7

20

F

2112

2942

72

9.2

7.0

 Sample 8

24

F

3218

3769

85

8.5

8.2

 Sample 9

19

M

1013

1916

53

8.2

8.7

 Sample 10

29

F

3411

4031

85

8.2

8.7

 Sample 11

26

M

5129

3923

131

7.5

9.0

  1. a TN-T1D samples were screened for the following autoantibodies: Glutamic acid decarboxylase 65 (GAD65), Islet cell autoantigen 512 (ICA512, also referred to as IA-2), micro Insulin autoantibodies (mIAA), and islet cell cytoplasmic autoantibodies (ICA). UF-T1D samples were screened for autoantibodies against glutamic acid decarboxylase (GADA), IA-2, and zinc transporter 8 (ZNT8)